These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28878657)

  • 1. Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib.
    Sorenson KR; Piovezani Ramos G; Villasboas Bisneto JC; Price K
    Case Rep Oncol; 2017; 10(2):726-731. PubMed ID: 28878657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen Deprivation Therapy for Intracranial Metastasis of a Salivary Duct Carcinoma: Case Report.
    Rösch M; Bieg C; Savic S; Buess M
    Case Rep Oncol; 2023; 16(1):109-115. PubMed ID: 36844935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report.
    Yang ZY; Huang JH; Chen B; Xu CW; Lei L; Wang XJ; Fang MY
    Front Oncol; 2020; 10():559057. PubMed ID: 33123470
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathologic study of salivary duct carcinoma and the efficacy of androgen deprivation therapy.
    Yamamoto N; Minami S; Fujii M
    Am J Otolaryngol; 2014; 35(6):731-5. PubMed ID: 25087467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
    Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
    Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy with trastuzumab for epidermal growth factor receptor 2 (HER2)-positive advanced salivary duct carcinoma: A case report.
    Gibo T; Sekiguchi N; Gomi D; Noguchi T; Fukushima T; Kobayashi T; Ozawa T; Yamada SI; Koizumi T
    Mol Clin Oncol; 2019 Aug; 11(2):111-115. PubMed ID: 31281644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature.
    You Y; Wang P; Wan X; Xu L; Gong Y; Zhang W
    Onco Targets Ther; 2021; 14():3481-3486. PubMed ID: 34093024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
    Thorpe LM; Schrock AB; Erlich RL; Miller VA; Knost J; Le-Lindqwister N; Jujjavarapu S; Ali SM; Liu JJ
    Head Neck; 2017 Mar; 39(3):E40-E44. PubMed ID: 28006087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic salivary duct carcinoma in cardiac and pleural effusions: A case report with immunocytochemical analysis for androgen receptor and HER2.
    Ito H; Ishida M; Sando K; Okano K; Ebisu Y; Fujisawa T; Iwai H; Tsuta K
    Mol Clin Oncol; 2019 Jan; 10(1):78-82. PubMed ID: 30655980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.
    Kawahara K; Hiraki A; Yoshida R; Arita H; Matsuoka Y; Yamashita T; Koga KI; Nagata M; Hirosue A; Fukuma D; Nakayama H
    Mol Clin Oncol; 2017 Jun; 6(6):886-892. PubMed ID: 28588783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of HER2+ metastatic salivary ductal carcinoma in a pregnant woman: a case report.
    Bergamini C; Cavalieri S; Sanguineti G; Farneti A; Licitra L
    Oxf Med Case Reports; 2019 Oct; 2019(10):omz102. PubMed ID: 31772741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.
    Krishnamurthy J; Krishnamurty DM; Baker JJ; Zhen W; Lydiatt D; Ganti AK
    Head Neck; 2013 Dec; 35(12):E372-5. PubMed ID: 23765450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
    Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
    Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
    Uijen MJM; Lassche G; van Engen-van Grunsven ACH; Tada Y; Verhaegh GW; Schalken JA; Driessen CML; van Herpen CML
    Cancer Treat Rev; 2020 Sep; 89():102069. PubMed ID: 32717621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.
    Park JC; Ma TM; Rooper L; Hembrough T; Foss RD; Schmitt NC; Sawhney R; Flanders A; Kang H
    Head Neck; 2018 Dec; 40(12):E100-E106. PubMed ID: 30478962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression assessment of the estrogen, progesterone and HER2 receptors in selected malignant tumors of the salivary glands].
    Golusiński W; Wegner A; Trzeciak P; Golusiński P; Sówka M; Kopczyński A; Bromboszcz M; Marszałek A
    Otolaryngol Pol; 2013; 67(5):245-51. PubMed ID: 24021827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report.
    Wasano K; Sakurai K; Kawasaki T; Kusafuka K; Kasahara M; Kondo N; Inada KI; Ogawa K
    Rare Tumors; 2018; 10():2036361318798867. PubMed ID: 30263102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
    Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
    Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological response of salivary duct carcinoma to trastuzumab and docetaxel therapy.
    Ueki Y; Tada Y; Togashi T; Kawakita D; Nagao T; Sato Y
    Int Cancer Conf J; 2016 Jul; 5(3):150-153. PubMed ID: 31149444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.